Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,769,079
-
Total 13F shares
-
60,335,883
-
Share change
-
-2,013,444
-
Total reported value
-
$1,076,382,910
-
Put/Call ratio
-
30%
-
Price per share
-
$17.84
-
Number of holders
-
125
-
Value change
-
-$49,077,961
-
Number of buys
-
74
-
Number of sells
-
42
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q1 2023
As of 31 Mar 2023,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,335,883 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, FEDERATED HERMES, INC., BlackRock Inc., NEA Management Company, LLC, VANGUARD GROUP INC, STATE STREET CORP, and Frazier Life Sciences Management, L.P..
This page lists
125
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.